Updates on the Treatment of Lupus Nephritis -- Immunotherapy
Lupus nephritis (LN) is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. Although the use of aggressive immunosuppression has improved both patient and renal survival over the past several decades, the optimal treatment of LN remains challenging.
The treatment of lupus nephritis has changed significantly over the past decade in large part because of data from well-conducted randomized clinical trials.
The histopathologic classification of lupus nephritis continues to guide therapy, and treatment for all major classes of lupus nephritis has seen some shift in management during this time. New regimens using immunotherapy have been advanced. We discuss new treatment strategies currently being explored in clinical trials.
Treatment of lupus nephritis: facing the era of immunotherapy
Immunotherapy is designed to regulate the abnormal immune system, which stops the inflammations and damages to native tissues, avoiding the relapse of lupus nephritis. Meantime, immunotherapy helps repair the damaged renal cells and tissues, thus to improve kidney functions.
Many people have Lupus Nephritis but don' t know immunotherapy. Click here to learn more about Current Recommended Treatment for Lupus Nephritis: Immunotherapy and find out if your disease can be treated.